Co-Authors
This is a "connection" page, showing publications co-authored by Alicia Fry and Aron Hall.
Connection Strength
1.730
-
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020 04 17; 69(15):458-464.
Score: 0.219
-
Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 2020. Clin Infect Dis. 2021 11 16; 73(10):1831-1839.
Score: 0.061
-
Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey. Clin Infect Dis. 2021 11 02; 73(9):e3120-e3123.
Score: 0.061
-
A Prospective Cohort Study in Nonhospitalized Household Contacts With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Symptom Profiles and Symptom Change Over Time. Clin Infect Dis. 2021 10 05; 73(7):e1841-e1849.
Score: 0.061
-
Shedding of Culturable Virus, Seroconversion, and 6-Month Follow-up Antibody Responses in the First 14 Confirmed Cases of Coronavirus Disease 2019 in the United States. J Infect Dis. 2021 09 01; 224(5):771-776.
Score: 0.060
-
Detection of SARS-CoV-2 on Surfaces in Households of Persons with COVID-19. Int J Environ Res Public Health. 2021 08 02; 18(15).
Score: 0.060
-
Changes in Influenza and Other Respiratory Virus Activity During the COVID-19 Pandemic - United States, 2020-2021. MMWR Morb Mortal Wkly Rep. 2021 Jul 23; 70(29):1013-1019.
Score: 0.060
-
Household Transmission of SARS-CoV-2 from Children and Adolescents. N Engl J Med. 2021 09 02; 385(10):954-956.
Score: 0.060
-
Estimating under-recognized COVID-19 deaths, United States, march 2020-may 2021 using an excess mortality modelling approach. Lancet Reg Health Am. 2021 Sep; 1:100019.
Score: 0.060
-
Estimated Incidence of Coronavirus Disease 2019 (COVID-19) Illness and Hospitalization-United States, February-September 2020. Clin Infect Dis. 2021 06 15; 72(12):e1010-e1017.
Score: 0.059
-
Risk Factors for Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization: COVID-19-Associated Hospitalization Surveillance Network and Behavioral Risk Factor Surveillance System. Clin Infect Dis. 2021 06 01; 72(11):e695-e703.
Score: 0.059
-
Risk Factors for Intensive Care Unit Admission and In-hospital Mortality Among Hospitalized Adults Identified through the US Coronavirus Disease 2019 (COVID-19)-Associated Hospitalization Surveillance Network (COVID-NET). Clin Infect Dis. 2021 05 04; 72(9):e206-e214.
Score: 0.059
-
Demographic, clinical, and epidemiologic characteristics of persons under investigation for Coronavirus Disease 2019-United States, January 17-February 29, 2020. PLoS One. 2021; 16(4):e0249901.
Score: 0.059
-
Estimated SARS-CoV-2 Seroprevalence in the US as of September 2020. JAMA Intern Med. 2021 04 01; 181(4):450-460.
Score: 0.059
-
Characteristics of Adults Aged 18-49 Years Without Underlying Conditions Hospitalized With Laboratory-Confirmed Coronavirus Disease 2019 in the United States: COVID-NET-March-August 2020. Clin Infect Dis. 2021 03 01; 72(5):e162-e166.
Score: 0.058
-
SARS-CoV-2 Transmission Dynamics in a Sleep-Away Camp. Pediatrics. 2021 04; 147(4).
Score: 0.058
-
Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths, December 2020. MMWR Morb Mortal Wkly Rep. 2020 Dec 11; 69(49):1860-1867.
Score: 0.057
-
COVID-19 Investigational Treatments in Use Among Hospitalized Patients Identified Through the US Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, March 1-June 30, 2020. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa528.
Score: 0.057
-
COVID-19-Associated Hospitalizations Among Health Care Personnel - COVID-NET, 13 States, March 1-May 31, 2020. MMWR Morb Mortal Wkly Rep. 2020 Oct 30; 69(43):1576-1583.
Score: 0.057
-
Symptoms and Transmission of SARS-CoV-2 Among Children - Utah and Wisconsin, March-May 2020. Pediatrics. 2021 01; 147(1).
Score: 0.057
-
Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 - COVID-NET, 13 States, March 1-August 22, 2020. MMWR Morb Mortal Wkly Rep. 2020 Sep 25; 69(38):1347-1354.
Score: 0.057
-
Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States. PLoS One. 2020; 15(9):e0238342.
Score: 0.056
-
Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020. MMWR Morb Mortal Wkly Rep. 2020 Aug 14; 69(32):1081-1088.
Score: 0.056
-
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020. JAMA Intern Med. 2020 Jul 21.
Score: 0.056
-
Investigation and Serologic Follow-Up of Contacts of an Early Confirmed Case-Patient with COVID-19, Washington, USA. Emerg Infect Dis. 2020 Aug; 26(8):1671-1678.
Score: 0.055
-
Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19 - United States, January-February 2020. MMWR Morb Mortal Wkly Rep. 2020 Mar 06; 69(9):245-246.
Score: 0.054
-
Persons Evaluated for 2019 Novel Coronavirus - United States, January 2020. MMWR Morb Mortal Wkly Rep. 2020 Feb 14; 69(6):166-170.
Score: 0.054